CT检测甲状腺癌患者颈部转移性淋巴结的诊断效能:系统评价与Meta分析
该系统评价与Meta分析纳入17项研究(6378例患者、11590枚淋巴结),评估CT诊断甲状腺癌颈部转移性淋巴结的效能,汇总敏感度55%(95%CI 47-63%)、特异度87%(95%CI 90-95%),CT协议差异是异质性的主要来源,CT在术前和术后诊断中均表现出可接受的诊断效能。
要点
- CT诊断甲状腺癌颈部转移性淋巴结的汇总敏感度为55%、特异度为87%。
- CT协议差异(对比剂用量、扫描期相、重建层厚)是研究间异质性的显著影响因素。
- 按颈部淋巴结分区行亚组分析可降低敏感度和特异度的异质性。
核心结论
- CT在甲状腺癌患者颈部转移性淋巴结的术前和术后诊断中表现出可接受的诊断效能。
- CT协议差异是纳入研究间诊断效能异质性的主要因素。
研究设计与样本
- 系统评价与Meta分析,检索Ovid-MEDLINE和EMBASE数据库截至2018年5月22日。
- 纳入17项研究,共6378例患者、11590枚淋巴结。
- 计算汇总敏感度和特异度,并行亚组分析和Meta回归分析评估异质性来源。
诊断标准与关键数值
- CT检测甲状腺癌颈部转移性淋巴结的汇总敏感度为55%(95%CI 47-63%)。
- CT检测甲状腺癌颈部转移性淋巴结的汇总特异度为87%(95%CI 90-95%)。
- 敏感度异质性I²=96.3%,特异度异质性I²=93.8%。
- 按颈部淋巴结分区行亚组分析后,敏感度和特异度的异质性均降低。
- Meta回归分析显示CT协议差异(对比剂用量、扫描期相、重建层厚)是异质性的统计学显著因素。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文报告敏感度异质性I²=96.3%、特异度异质性I²=93.8%,异质性显著。
- 原文报告CT协议差异(对比剂用量、扫描期相、重建层厚)是异质性的显著因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Although ultrasound (US) is a standard modality for the assessment of cervical lymph node metastasis in patients with thyroid cancer, there is an increasing trend in the number of articles describing the use of contrast-enhanced computed tomography (CT). The purpose of this systematic review and meta-analysis was to evaluate the diagnostic performance of CT in the diagnosis of metastatic cervical lymph nodes and to identify the parameters responsible for heterogeneity in diagnostic performance.
METHODS: Ovid-MEDLINE and EMBASE databases were searched up to May 22, 2018, for studies on the diagnostic performance of CT. The pooled sensitivity and specificity of all studies were calculated. In addition, subgroup analysis and meta-regression analysis were performed to evaluate factors responsible for heterogeneity.
RESULTS: Seventeen (6378 patients, 11,590 lymph nodes) studies were included. The pooled sensitivity was 55% (95% CI, 47-63%), and the pooled specificity was 87% (95% CI, 90-95%). Higgins I2 statistic demonstrated substantial heterogeneity in the sensitivity (I2 = 96.3%) and specificity (I2 = 93.8%). In a per-neck level subgroup analysis, the Higgins I2 statistic demonstrated reduced heterogeneity in both sensitivity and specificity. In the meta-regression analysis, variation in the CT protocols, such as contrast amount, scan phase, and reconstruction slice thickness, was a statistically significant factor causing heterogeneity.
CONCLUSIONS: CT demonstrated acceptable diagnostic performance in the pre- and postoperative diagnosis of metastatic cervical lymph nodes in patients with thyroid cancer. Variation in the CT protocols was a main factor causing heterogeneity among the included studies.
KEY POINTS: • The role of contrast-enhanced computed tomography (CT) needs to be reassessed. • CT demonstrated acceptable diagnostic performance in the diagnosis of metastatic cervical lymph nodes in patients with thyroid cancer in the meta-analysis. • Variation in the CT protocols was a main factor causing heterogeneity in the meta-regression analysis.
引用
- Cho SJ, Suh CH, Baek JH, et al. Diagnostic performance of CT in detection of metastatic cervical lymph nodes in patients with thyroid cancer: a systematic review and meta-analysis. Eur Radiol. 2019. PMID: 30806803. doi:10.1007/s00330-019-06036-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。